Cost analysis for the return and disposal of expired Navy pharmaceuticals by Rundstedt, Ronald J.
Calhoun: The NPS Institutional Archive
Theses and Dissertations Thesis Collection
1993-12
Cost analysis for the return and disposal of expired
Navy pharmaceuticals
Rundstedt, Ronald J.
Monterey, California. Naval Postgraduate School
http://hdl.handle.net/10945/39743
NAVAL POSTGRADUATE SCHOOL Q
N Monterey, California
ELECTE't
MAR 2 5 1994D A
F
THESIS
COST ANALYSIS FOR THE RETURN AND
DISPOSAL OF EXPIRED NAVY
PHARMACEUTICALS
by
N-. Ronald J. Rundstedt
0--- December, 1993
Principal Advisor: Katsuaki L. Terasawa
Approved for public release; distribution is unlimited.
94 3 24 0 71
STT •2) I.
REPORT DOCUMENTATION PAGE 
Form Approved OMB No. 0704
Public reportung burden for this collection of information is estimated to average I hour per response, including the time for reviewing instruction.
searching existing data sources. gathaerig said maintaining the data needed, and completing and reviewing the collection of infonmation. Send comments
regarding this burden estimate or any other aspect of this collection of information. including suggestions for reducing this burden, to Washington
headquarters Services, Directorate for Information Operations and Reports. 1215 Jefferson Davis Highway. Suite 1204, Arlington, VA 222024302. and to
the Office of Management and Budget, Paperwork Reduction Project (0704-0188) Washington DC 20503.
1. AGENCY USE ONLY (Leave blank) 2. REPORT DATE 3. REPORT TYPE AND DATES COVERED
16 December 1993 Master's Thesis
4. TITLE AND SUBTITLE Cost Analysis For The Return And Disposal 5. FUNDING NUMBERS
Of Expired Navy Pharmaceuticals
6. AUTHOR(S) Rundstedt, Ronald J.
7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING
Naval Postgraduate School ORGANIZATION
Monterey, CA 93943-5000 REPORT NUMBER
9. SPONSORING/MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSORING/MONITORING
AGENCY REPORT NUMBER
11. SUPPLEMENTARY NOTES The views expressed in this thesis are those of the author, and do not
reflect the official policy or position of the Department of Defense or the U.S. Government.
12a. DISTRIBUTION/AVAILABILITY STATEMENT 12b. DISTRIBUTION CODE
Approved for public release; distribution is unlimited. A
13. ABSTRACT (maximum 200 words)
One objective of this study was to quantify the dollar amount of savings that the Navy could expect
if they return their expired pharmaceutical products. Another objective was to determine whether it is
cost effective to contract civilian services for the return and disposal of these expired products.
The scope of the study was limited to the continental United States Naval Military Treatment
Facilities (CONUS MTFs). Based on inferential methods in linear regression, it was determined that
the dollar amount that the Navy can expect to recoup, through the return of their expired
pharmaceuticals at CONUS MTFs, is over two million dollars per year. Also, after analyzing and
comparing four.alternatives, a conclusion was made that contracting civilian services would be the
most cost effective method for the return and disposal of expired Navy pharmaceutical products.
A recommendation was made that the Navy initiate a universal policy directing the return and
disposal of expired pharmaceutical products utilizing civilian services.
14. SUBJECT TERMS Military, Expired Pharmaceuticals, Returned Goods, 15. NUMBER OF
Military Treatment Facility, Cost Analysis. PAGES * 91
16. PRICE CODE
17. SECURITY CLASSIFI- 18. SECURITY CLASSIFI- 19. SECURITY CLASSIFI- 20. LIMITATION OF
CATION OF REPORT CATION OF THIS PAGE CATION OF ABSTRACT ABSTRACT
Unclassified Unclassified Unclassified UL
NlSN 7/)4U4)I-280-55•O Standiard Porm 298 (Rev. 2-89)
Prescribed by ANSI Std. 239-18
Approved for public release; distribution is unlimited.
Cost Analysis For The Return And




Commander, United States Navy
B.S.E.E., University of Notre Dame, 1978
Submitted in partial fulfillment
of the requirements for the degree of







K~tsuaki L. Terasawa, Principal Advisor
Louis G. Kalmar'*ssociate Advisor
Da~v R. Whi•• .,ChairmanDepartment of A~d sr~ative" Sciences
....
ABSTRACT
One objective of this study was to quantify the dollar amount of savings that the
Navy could expect if they return their expired pharmaceutical products. Another objective
was to determine whether it is cost effective to contract civilian services for the return and
disposal of these expired products.
The scope of the study was limited to the continental United States Naval Military
Treatment Facilities (CONUS MTFs). Based on inferential methods in linear regression, it
was determined that the dollar amount that the Navy can expect to recoup, through the
return of their expired pharmaceuticals at CONUS MTFs, is over two million dollars per
year. Also, after analyzing and comparing four alternatives, a conclusion was made that
contracting civilian services would be the most cost effective method for the return and
disposal of expired Navy pharmaceutical products.
A recommendation was made that the Navy initiate a universal policy directing the
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In the 1980s, the focus of Navy Medicine had been on the
provision of quality care with less emphasis on the rigorous
management of fiscal resources. There had been typically both
constant dollar and real growth in each new budget, with
little or no reduction, or deletion, of original line items.
(Bruhn, 1992)
Now, in an era of economic downturn, the budget deficit,
the collapse of the Soviet Empire, and public clamor to reap
a peace dividend, there will be a continued decline in future
military budgets.
To offset the current, and projected, large reductions in
the budget, the Secretary of Defense has implemented cost
savings initiatives that include base realignments and
closures (BRAC), consolidation of commands, reduction of force
levels, implementation of unit costing, and emphasis on Total
Quality Leadership (TQL) (Bruhn, 1992). While some savings
have been achieved, fiscal problems persist.
Throughout times of tight constraints on resources, the
U.S. Department of Defense must continue to maintain its vital
mission of military preparedness, as well as to execute its
medical mission more effectively (Lanier, 1993).
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One of the foremost management challenges being debated
among mil-_*tary health care leaders is how best to improve
access i:o quality care and achieve economies, without
reduciLig the health care benefit. Even more serious is
tha,_ this challenge occurs at a time when fundamental
questions are being raised about the efficacy of the
organization and operation of the military's own vast and
enormously complex health care system. (Lanier, 1993)
As new management methods and technologies evolve in the
health care logistics management industry, military medical
personnel must seize those opportunities, and exploit their
potential for enhanced efficiency and improved military
readiness (Blaker, 1991) . "In an effort to maximize cost
containment within the military budget, an often untapped
source of additional revenue is the return of outdated
pharmaceutical products to drug manufacturers for credit or
replacement products (Capital Returns, Inc., 1993)."
B. BACKGROUND
The United States Navy Bureau of Medicine and Surgery is
responsible for the operation of 33 hospitals in the United
States and overseas (four of which are major multi-
disciplinary teaching hospitals and four of which are family
practice teaching hospitals) , and 174 medical clinics and
dental clinics. These are exclusive of facilities on Navy
ships and in Marine Corp units. Each of these facilities
handles pharmaceutical products. A by-product of normal
operations is the accumulation of expired pharmaceutical
products.
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Currently, most Navy facilities do not return expired
pharmaceutical products for cash, credit, or replacement
products because it is labor and time intensive. Each line
item must be cataloged by manufacturer, lot number, quantity,
and purchase price. As a result, most facilities discard the
expired pharmaceuticals. (Kinney, 1993)
The disposal of pharmaceuticals is subject to increasing
scrutiny from local, state, and federal agencies as
environmental concerns escalate. This increases the
administrative burden to pharmacies and exposes Navy medicine
to criticism, or potential legal problems. (Kinney, 1993)
There are companies that provide return and disposal
services for hospitals and pharmacies, and charge a fee for
that service. Additionally, these companies specialize in the
destruction of expired pharmaceuticals and have the requisite
expertise to meet local, state, and federal regulations
(Kinney, 1993).
C. OBJECTIVE
One objective of this study was to quantify the dollar
amount of savings that the Navy could expect if they return
their expired pharmaceutical products. Another objective was
to determine whether it is cost effective to contract civilian
services for the return and disposal of these expired
products.
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D. SCOPE, LIMITATIONS, AND ASSUMPTIONS
1. Scope
Although the problem of expired pharmaceuticals is
prevalent through the entire Federal Government, this study
focused on the Department of the Navy. Specifically, the
hospitals and clinics that are located in the continental
United States (CONUS) were studied. These facilities are
under the. jurisdiction of the Bureau of Medicine and Surgery.
The hospitals and clinics used for data collection
were selected by the Navy Surgeon General's Specialty Advisor
for Pharmacy. They are a representative sample of the entire
continental United States Navy health care system, and each
facility had been returning their expired pharmaceuticals.
Data obtained came from individual pharmacy records, civilian
return company records, and Navy Health Care databases.
2. Limitations
For the purposes of this study, the following
limitations were identified:
"* Due to time, telephone, and logistics constraints, only
continental United States Naval Medical Treatment
Facilities (MTFs) were studied. Alaska, Hawaii, and
overseas MTFs were not studied.
"* Data was scarce because few government facilities are
currently returning their expired pharmaceutical products.
Also, those facilities that are returning their expired
pharmaceuticals have only been doing so for a short time.
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3. AsmuMptions
For the purposes of this study, it was assumed that:
Naval MTFs are similar to all other medical facilities in
some ways. Both are responsible for providing quality
inpatient and outpatient health care, use the same or
similar supplies, and provide training to physicians and
other health care personnel. In addition, both must
control the cost of health care as prices for supplies and
equipment escalate. (Bruhn, 1992)
• Any recognized means to reduce costs, without a subsequent
decline in the quality of service, are applicable to both
Naval MTFs and all other medical facilities (Bruhn, 1992).
* Naval MTFs and other military medical facilities are
di.fferent from civilian facilities in several ways.
E_.st, military facilities do not charge their patients
for services rendered. Second, military facilities are
generally smaller in size, but they generally treat more
outpatients than their civilian counterparts. Third,
military facilities also serve as pharmacies for active
and retired military personnel and their dependents, while
private sector pharmacies are largely separate and
independent from medical facilities. (U.S. GAO, 1991)
E. DEFINITIONS AND ABBREVIATIONS
For the purposes of this study, the following definitions
will be used:
"* Ancillary Services - Those services (functions) that
participate in the care of patients principally by
assisting and augmenting the talents of attending
physicians and dentists in diagnosing and treating human
ills. Ancillary Services generally do not have primary
responsibility for the management of patients. Rather,
patient services are provided on the orders of cognizant
physicians and dentists. Pharmacy services are an example
of ancillary services.
"* Authorized Medical Allowance List (AMAL) - The authorized
allowances of medical equipment and consumable supplies
required to accomplish health care support under combat
conditions. Establishes the minimum quantities that are
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to be maintained on board U.S. naval vessels at all times.
(BUMEDINST 6700.13F)
"* Bassinet Days - The count of total days that newborn
infants occupy bassinets in MTFs that have bassinets
assigned for infant use. The total count includes each
day. an infant occupies a bassinet at the census-taking
hour (usually midnight).
Source: HIPS.
"* Catchment Area - A uniformed service MTF catchment area is
defined by OASD(HA) as the five digit zip code zones whose
geographic center lies within 40 miles of the center of
the zip code zone in which the MTF is located. Naval
Medical Clinics Commands do not have designated catchment
areas, only inpatient facilities.
"* Dated Drug Product - To assure that a drug product meets
applicable standards of identity, strength, quality, and
purity at the time of use, it shall bear an expiration
date determined by appropriate stability testing. (211.137
CFR)
"* Manufacturer - The functions of the ethical pharmaceutical
manufacturing industry may be classified into four groups:
research and development, production of medicinal
chemicals, formulation of drugs into the various dosage
forms (such as tablets, capsules, ointments, and
injectable solutions), and marketing. Not all
pharmaceutical manufacturers combine into one organization
the four functional classifications, though this is the
common concept. (King, 1968)
"• Military Medical Treatment Facility (MTF) - A MTF is a
health care facility equipped to provide various degrees
of outpatient and/or inpatient care. In the Navy, this
includes fixed hospitals, clinics, sickbays and land-based
mobile facilities. (Standard Element Activity Reporting
System (SEARS) Report)
"* Naval Medical Logistics Command (MEDLOG) - Provides
medical logistic and materiel management support to the
Fleet, Fleet Marine Forces, and ashore medical and dental
treatment facilities.
"* Prime Vendor - In November 1991, Veterans Administration
(VA) implemented a prime vendor program that should reduce
the number of pharmaceutical products stored in selected
VA warehouses and medical centers. The prime vendors are
drug wholesalers that have been awarded contracts for the
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warehousing and subsequent distribution of pharmaceutical
products to individual medical centers. VA negotiates
prices and awards contracts for products directly with the
manufacturers or suppliers. The prime vendor in turn buys
the products at these prices and distributes the products
to the hospital. It charges a distribution fee for these
inventory management and distribution services. (U. S.
GAO, 1991)
Shelf-Life - The period of time beginning with the date of
manufacture/cure/assembly and terminated by a date by
which the item must be used or subjected to
inspection/test/restorative disposal action. For medical
commodities, the term shelf-life refers only to expiration
dated (potency) items. (Aguigam, 1991)
• Weighted Procedures - If the performance factors
(workload) were homogenous, the cost per procedures would
be simply obtained by dividing the total cost of a work
center by the number of procedures performed by that work
center. However, two results occur: (1) the relative
costs of the various procedures performed becomes grossly
distorted and (2), relative workloads become
noncomparable. Hence, in order to obtain average useful
cost comparison data, it is necessary to assign weighted
values which reflect their relative complexities and
costliness. Typically, a workload procedure is "weighted"
to accurately and fairly account for the value of the
resources consumed to accomplish or produce that given
performance (workload) unit. The pharmacy procedures
weighted values are as follows:
Pharmacy Procedures Weighing Factors
a. Prescription 1.0
b. Clinic Issue 0.6
c. Sterile Product 2.0
d. Unit Dose 0.15
e. Bulk Issue 2.0
Prescription - Written order for a medication or device
prescribed for an individual patient. A refill is counted
the same as a Prescription.
Clinic Issue - A handout or prepared issue to a clinic for
subsequent issue to individual patients by non-pharmacy
personnel.
Sterile Product - Each parenteral bottle, bag, or syringe
that is prepared by the pharmacy and is ready for
administration.
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Unit Dose - An individual dose.
Bulk Issue - Each line item issued to clinic wards to be
used within the clinic or ward.
Wholesaler - The wholesaler is an essential link in the
channel of distribution that connects drug manufacturers
with consumers. Most ethical drug products are sold to
wholesalers. The wholesale druggist is also necessary to
the pharmacy. The indispensability of the wholesaler is
illustrated by the fact that a single large drug outlet
may stock as many as 100,000 items. Most of these are
purchased in small quantities. Thousands of these items
are ordered one at a time. It is obviously not
economically feasible for each pharmacy to attempt to deal
directly with each of the thousands of manufacturers. A
single wholesaler, acting as an intermediary, permits the
pharmacy to handle the merchandise of thousands of
manufacturers with moderate effort and expense. (King,
1968)
F. ORGANIZATION OF STUDY
Succeeding chapters of this study will focus on the
following areas.
Chapter II presents information, and introduces background
issues, that apply to the return and disposal of expired Navy
pharmaceutical products.
Chapter III presents the methodology used in conducting
the study, and the structure of the analysis.
Chapter IV presents the data and an analysis of that data.
Chapter V (1) provides a summary of the study, (2)
concludes that civilian services should be used for the return
and disposal of expired Navy pharmaceutical products, and (3)
recommends that the Navy initiate a universal policy directing
8
the return and disposal of expired pharmaceutical products
utilizing civilian services.
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11. LITVZRTURZ RZVIZW AND BACKGROUND ISSUZS
This chapter will present information, and introduce
specific background issues, that apply to the return and
disposal of expired Navy pharmaceutical products.
A. THU PHARMACY
According to DoD Directive 6010.13M, Medical Expense and
Performance Reporting System (MEPRS) Manual:
The pharmacy produces, preserves, stores, compounds,
manufactures, packages, controls, assays, dispenses, and
distributes medications (including intravenous solutions)
for inpatients and outpatients. Additionally, the
pharmacy plans and technically supervises all
pharmaceutical activities of the medical facility;
advises and makes recommendations on policies, standards,
and practices; informs professional personnel of new
medicinal and biological preparations; and establishes
safeguards for storing and issuing poisons, narcotics, and
alcoholic drugs. Other pharmacy services include the
maintenance of formularies; maintenance of patient drug
profiles; adding drugs to intravenous solutions;
determining incompatibility in drug combinations;
administering unit dose drug combinations; administering
unit dose drug distribution system; and stocking floor
(ward) drugs and satellite pharmacies.
Pharmacy costs are in a summary account that includes
all operating expenses incu~red in operating and
maintaining the pharmacy. Proration of nonpersonnel
expenses for jointly operated or used facilities are based
on work load. Proration of personnel expenses are based
on time spent in each work center. The aggregate of these
expenses are ultimately assigned through a stepdown
process to other ancillary services and final operating
expense accounts. Aggregate expenses are assigned based
on the ratio of weighted procedures provided each
receiving account (the work center that ordered the
services or was the beneficiary of the services) to the
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total weighted procedures provided by this work center.
(MEPRS Manual)
By far, the largest expense in Navy MTF pharmacies is that for
pharmaceutical products.
S. THE NEED - PHARMACRUTICAL PRICES ARE RISING
Pharmaceutical prices have been rising more rapidly than
both medical care prices and consumer prices in general, as
measured by the Consumer Price Index for medical care, and for
all items (CPI - all items) (Cleeton, 1992).
Total expenditures for drugs and sundries have grown at
remarkably stable rates over the last 25 years- -average
annual growth rates of drug expenditures for 5-year
periods from 1965 to 1990 have not been lower than 8.1
percent nor higher than 10 percent.
Prescription drug (pharmaceutical) prices have followed
a different pattern than prices in general. They fell
uniformly from the 1960s through the mid-1970s relative to
overall price levels in the economy. F-.om the mid-1970s
through 1981, they grew at about the same rate as overall
prices, and since then they have grown much more rapidly
than have general prices. (Sonnefeld, 1991)
Between 1980 and 1990, while the general inflation rate
was 58 percent, prescription drug price inflation was three
times this -- 152 percent. In October 1991, a staff report by
Senator David Pryor's Special Committee on Aging indicates
that, far from being an aberration, these startling price
increases are actually accelerating, reaching their highest
rate of increase in a decade. (Senate, October 16, 1991)
With prices expected to continue their rapid growth, Navy
health care managers must use every effort to minimize the
effects of the rise.
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C. AN OPPORTUNITY PROVIDED BY THE MANUFACTURERS
As stated in the Code of Federal Regulations:
A drug product may be reprocessed provided the
subsequent drug product meets appropriate standards,
specifications, and characteristics. Records of returned
drug products shall be maintained and shall include the
name and label potency of the drug product dosage form,
lot number, reason for the return, quantity returned, date
of disposition, and ultimate disposition of the returned
drug product. (211.204 CFR)
Because of the above regulation, and in an effort to
retain customers by goodwill, throughout the ethical drug
industry it is common practice to accept expired
pharmaceutical products for return and issue refunds,
merchandise credit, or replacement products.
Products purchased through the Federal Supply Schedule
and local purchase are eligible for return in accordance
with the manufacturers' policies for the commercial
sector. In examining the policies of 72 of the leading
drug manufacturers, ... 20 will accept outdated
pharmaceuticals with no time limit, although discounting
does occur depending on the age of the products. Six will
accept outdates between two and five years from the date
of expiration, and 36 will accept products within one year
of expiration. Ten have a six month time limit.
In addition to the time constraints, there are
additional requirements attached to some of the policies,
such as fulls only, unmarked containers, original
packaging, certain products only, etc. In spite of these
limitations, a systematic program for returning outdates
in a timely manner will more than cover the cost of
processing. (Capital Returns, Inc., 1993)
Examples of manufacturer policies are in Appendix A. These
manufacturer policies present an opportunity that Navy health
care managers can exploit.
12
D. ZXPZRUD PHARMACEUTICAL PRODUCTS - WHERR THEY ORIGINATE
While the problem of returned goods is not unique to the
ethical drug industry, the problem is intensified because most
of the products are "dated". Hospital and clinic pharmacies
are required to maintain sufficient stock to service their
customers. However, overstocking, and subsequent expiration,
is inevitable due to variables in patient quantities, types of
illnesses, and specific drug and dosage requirements. This is
especially true in the larger teaching hospitals.
Teaching hospitals are distinguished by their patients'
severity of illness and/or complexity of diagnosis, the
comprehensiveness and/or intensity of services offered, and
their institutional commitment to providing medical education
(Baumgardner, 1992).
They also maintain most of the highly specialized care
units, such as trauma centers; burn units; medical,
surgical, pediatric, and neonatal intensive care units
(ICUs); coronary care units; transplant programs; and
cancer treatment centers. Because teaching hospitals
have the highest degree of control of essential
support services and interdependence of units, they
demand high levels of specialized pharmaceutical
services. (Baumgardner, 1992)
These complex organizations generate more annual pharmacy
costs per occupied bed, have a greater array of pharmaceutical
products, and have a greater problem with stock expiring than
non-teaching hospitals.
Rotation of stock, in any hospital or clinic pharmacy, is
necessary to ensure items with the least amount of shelf-life
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are used first. Due to poor management of stock, occasionally
items expire that could have been used.
Additionally, in today's complex markets it is normal that
some new products will not gain wide acceptance, or some older
products fall out of favor. Competition from other products,
dissatisfaction with performance, and patient feedback
concerning adverse reactions result in physicians choosing
alternatives. Expected usage may not be met, and as a result
certain stocked products expire.
Excess pharmaceutical products originate from other
military specific sources:
"• Base realignments and closures have produced surpluses as
hospitals and clinics shut down or downsize.
"* Ships departing on deployment must maintain an AMAL
stocked with products that will not expire while on the
deployment. Any items that do not meet this requirement
will usually be given to the local MTF for their use and
disposition. Likewise, ships returning from deployment
will often offload unnecessary products to the local MTF,
so they can be used before expiration. This practice can
produce surpluses, and subsequent expirations.
"• A unique function of the DoD medical care system is to
provide care of its troops during wartime. To prepare for
this contingency, MEDLOG Depots store additional medical
supplies (called "war reserve" material) that can be used
in the early stages of a conflict. When stocks of these
"war reserve" materials are rotated, the depots issue them
to peacetime operating MTFs. These items are closer to
their expiration date, and may not be completely exhausted
prior to expiration.
R. METHODS OF MANAGING EXPIRED PHARMACEUTICALS
Currently, most Navy MTFs are not returning their expired
pharmaceutical products. Of the few that do, one has a
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contract with a civilian return company, and the others are
accomplishing the returns with internal assets.
If the expired products are not being returned, they are
collected for disposal. The larger hospitals box the expired
materials and send them to a centralized location for
disposition. The smaller hospitals and clinics usually handle
their expired materials inside the pharmacy spaces. After
collection, the materials are sorted between hazardous and
non-hazardous. The hazardous materials are shipped along with
other hazardous hospital waste to an approved incinerator for
destruction. The non-hazardous materials are usually put in
dumpsters for pickup by a refuse company, which transports the
waste to the local landfill.
The Navy MTFs which are performing the return functions
themselves must go through a process similar to that of the
civilian return companies. First, the manufacturers must be
contacted to obtain their individual return policies and
return forms. Expired pharmaceutical products must then be
sorted/separated by manufacturer. The products are then fine
sorted 'according to the individual manufacturer policy.
Products that are returnable are inventoried, forms prepared
(filled out indicating: product name, dosage form, lot number,
reason for the return, expiration date, and quantity returned;
examples are in Appendix B), and packed and shipped to each
individual manufacturer. Refunds, credit, or replacement
products are then issued to the pharmacy directly from the
15
manufacturer, or through their wholesaler. The products that
are not returnable must be disposed of after determining
hazardous and non-hazardous waste. This is illustrated in
Figure 1. (Capital Returns, Inc., RX Returns, Inc., 1993)
RETURN GOODS PROCESSING
P11A~A4%A-CY H1ANDML1ES kMRETURNS
. •I b NI--10
Figure i: Return Goods Processing Pharmacy Handles Returns
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When a civilian return service is used, the Navy
pharmacies must gather the expired products and either box and
ship them to the return company, or have them picked up
directly by the return company. After that is completed, the
civilian return service performs all aspects of the returns.





Figure 2: Return Goods Processing Using Civilian Services
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F. ISSUMS
There have been several issues that have emerged
concerning expired pharmaceutical products.
1. Disposal
In the past, it was common to ignore the effects on
the environment when disposing of pharmaceutical waste. Now,
with the increase in sensitivity to the impact of all
industrial waste on the environment, it becomes essential to
consider how current disposal operations affect, and are
perceived to affect, the air and water.
Enforcement of the Clean Air Act has resulted in the
closure of many hospital incinerators, leaving pharmacies no
internal method for the disposal of pharmaceutical waste.
Additionally, many biomedical waste facilities are not
permitted to accept pharmaceuticals, which are now designated
as "special waste." "Special waste" must be incinerated at an
approved site. (Capital Returns, Inc., 1993)
In addition to Federal regulations; state, local,
Occupational Safety and Health Administration (OSHA), DoD, and
other regulations must be followed for proper destruction of
pharmaceutical products. With a continuing barrage of new
regulatory requirements, significant changes must occur. The
practice of pouring expired solutions down the drains, and/or
flushing pills down the toilets, is finished.
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2. Manufacturers' Policies
In a study of pharmaceutical returns, Joel Winterton
found that:
The pharmaceutical industry is currently under attack
from a host of external influences to radically improve
the manner in which returned goods are processed,
accounted for, disposed of and handled.
Historically, manufacturers and wholesalers have made
significant efforts to automate their order entry systems
and order fulfillment process. In addition, their
physical distribution processes and management measurement
systems are geared toward achieving high order fill rates,
maximizing inventory turns and minimizing inventory
carrying costs.
Unfortunately, these distribution systems tend to be
highly inefficient in the processing, handling, and
accounting for products being moved in reverse fashion
through the system. (Winterton, 1992)
This can create confusion and dissatisfaction for the
hospitals and clinics who are attempting to return their
expired goods. Additionally, manufacturers frequently change
their return policies. Keeping a current database of the
policies is extremely time and labor intensive.
3. Manufacturer Credits and Refunds
When expired pharmaceuticals are returned, the
manufacturers may issue refunds, merchandise credit, or
replacement products. Replacement products do not present
problems with execution, but credits and refunds do.
The nature of the Navy accounting transaction cycle
causes a problem with manufacturer credits. When
requisitioning pharmaceuticals, an obligation (legal
reservation of funds) is established and sent by the MTF's
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comptroller to the appropriate Defense Accounting Office
(DAO). After the DAO receives subsequent documentation from
the comptroller that the pharmaceuticals have been
received/accepted, the DAO pays the bill. If there are
manufacturer credits from returns of expired goods, they
sometimes continue to accrue. Follow-on requisitions cannot
be processed using the offsetting credits to reduce the amount
of the obligation. The full purchase price must be obligated
by the MTF. An ensuing bill from the manufacturer will then
be paid by the DAO. Due to this accounting restriction, some
MTFs have had to request that the manufacturer send them a
check in the amount of their accumulated credits.
Title 31, Section 3302 of the United States Code
states: "... an official or agent of the Government receiving
money for the Government from any source shall deposit the
money in the Treasury as soon as practicable .... "1 (31 U.S.C.
3302) Additionally, the Navy Comptroller Manual requires that
proceeds from the sales of DoD excess, scrap, and surplus
personal property be deposited promptly to the U.S. Treasury
account. Returning expired pharmaceuticals for refunds (cash
or checks) can be considered selling scrap or surplus DoD
property. Depositing those proceeds in the Treasury, rather
than hospital/clinic accounts, helps the Treasury's general
fund. However, the regulations as written do not provide an
incentive for the MTFs to pursue returning expired
pharmaceuticals when they might expect refunds.
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This chapter gave the backdrop in which the study was
conducted. The next chapter will describe the methods used
for executing the study, and the structure for the analysis.
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XII. IlTHODOLOGY
There were two distinct objectives to this study. The
first was to quantify the dollar amount of savings that the
Navy could expect if they return their expired pharmaceutical
products. Another was to determine whether it is cost
effective to contract civilian services for the return and
disposal of these expired products.
A. DOLLAR AMOUNT OF NAVY RETURNS
To. determine the dollar amount of expected savings,
inferential methods in multiple linear regression were used.
First, it was determined whether one, two, or more predictor
variables were related to the dollar amount that pharmacies
recouped when returning their expired pharmaceuticals, and how
they were related. Then, after determining the best-fitting
lines for the sample data set, those sample regression
equations were used to make predictions about the population
(CONUS hospitals/clinics). This yielded an estimate for the
average dollars recouped per month. Multiplying by twelve
gave an arnual estimate for Navy returns.
To perform statistical inferences in multiple
regression, it is necessary that the variables under
consideration satisfy certain conditions. For multiple
regression with k predictor variables, those conditions
are as follows:
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Assumptions for Multiple Regression Inferences
1. Population regression equation: For each set of
values, x1, x 21 ... , Xk, of the predictor variables, the
mean of the corresponding population of y-values is B0
Bx + ... + Bk. The equation
y = BO + B1 x + ... + B. k
is called the population regression equation.
2. Equal standard deviations: The standard
deviation, 1, of the population of y-values
corresponding to a particular set of values, xj,
X2,..., Xk, of the predictor variables is the same,
regardless of xj, x21 ... , Xk.
3. Normality: For each set of values, xj, x21 .... Xk,
of the predictor variables, the corresponding
population of y-values is normally distributed.
So, Assumptions 1, 2, and 3 require that there exist
constants, BO, B1, ... , Bk, and a, such that for each set of
values, x, x21 ... , Xk, of the predictor variables, the
corresponding population of y-values is normally
distributed with mean BO + B~x, + ... + BkXk and standard
deviation C. These assumptions are often referred to as
the multiple regression model. (Weiss, 1991)
To interpret the coefficients, B1, B2, ..... Bk, the
coefficient, B,, of the predictor variable, x,, represents the
change in the mean of the population of y-values for every
increase in x. by one unit, with all other predictor variables
held fixed. (Weiss, 1991)
When a sample regression equation is determined, 9 = bo+
bjxj + ... + bkxk, what is obtained is the best estimate, based
on the sample data, of the (unknown) population regression
equation, y = B0 + B1xj + . ... + BkXk. In fact, for each j, bi
is the best estimate of B,. (Weiss, 1991)
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The predictor variables considered for the sample
regression equation were the following:
"* Admissions - Comprised of the total number of patients
admitted for treatment or observation in the hospital
(including newborns). Patients transferred from one
facility to another are included in the count of
admissions at both facilities. The admission of a newborn
occurs at the time of birth. Numbers are for the period:
FY 91, FY 92, and the first six months of FY 93.
Source: Headquarters Inpatient System (HIPS).
"• Average Daily Patient Load (ADPL) - Average number of
patients occupying beds per day in a fixed inpatient
Medical Treatment Facility (MTF) during a given time
period:
total # of occupied bed days (including bassinet days)
number of days in report period
Source: Derived from the HIPS based on FY data.
"* Average Length of Stay (ALOS) - The average number of
occupied bed days for patients (including newborns)
admitted to a facility during a given time period:
total # of occupied bed days for patients admitted
number of admissions during period
Source: Derived from the HIPS based on FY data.
"• Catchment Area Population Estimates - Defense Medical and
Information System (DMIS) counts are developed for the
Office of the Assistant Secretary of Defense (Health
Affairs) OASD(HA) under contract by Vector Research, Inc.
The FY 92 data are projections from the RAPS model and are
based primarily on counts of eligible beneficiaries
enrolled in the Defense Enrollment Eligibility Reporting
System (DEERS) as of 30 September 1991, the total service
POM active duty endstrength projections, projected
estimates of retirees by age groups obtained from
OASD(HA)/HB&P, and growth rate of paid retirees as
reported by the office of the DoD Actuary, adjusted for
regional migration patterns computed from historical DEERS
data. The data presented are obtained for observations at
a single point in time, and, therefore, may not take into
account the user's knowledge of recent shifts or movement
of personnel. DMIS provides population estimates by
beneficiary category, sponsoring service, sex, and age
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group. The DMIS methodology makes several assumptions
regarding beneficiary population location which are
significant to Navy and Marine Corps. Sponsors are
assigned to catchment areas based on the five digit zip
code of work assignment contained in the DEERS database.
If the zip code of work assignment is a Fleet Post Office
(FPO) zip code, active duty personnel were assigned to
catchment areas based on the location of the Unit
Identification Code (UIC). Dependents of active duty were
allocated to catchment areas based on the five digit zip
code of their residence. The population module now
accounts for base realignments and closures (BRAC). User
selection of project years automatically incorporates the
series of modifications corresponding to the BRAC changes
for the years prior to and including the selected
projection year. Output reports are marked with the
currently implemented version of BRAC.
Source: Defense Medical and Information System.
Occupied bed days - Represents the count of total days
that patients occupy beds (including bassinets and Alcohol
Rehabilitation) in MTFs that have beds assigned for
patient use. The total count includes each day a patient
occupies a bed at the census-taking hour (usually
midnight). Days on pass, or liberty not in excess of 72
hours, newborn infant days while occupying a bassinet, and
days in the labor or delivery room are also counted as
occupied bed days. In addition, an occupied bed day is
credited whenever a patient is admitted and discharged on
the same day, such as from same day surgery. However,
days during which patients on an MTF census are subsisting
out, on convalescent leave, on authorized or unauthorized
leave in excess of 72 hours, or in a transient status are
not counted as occupied bed days. Numbers are for the
period: FY 91, FY 92, and the first six months of FY 93.
Source: HIPS.
• Operating Beds - Accommodation in a functioning MTF that
is currently set up and ready in all respects for patient
care. Includes supporting space, equipment, medical
material, ancillary support services, and staff to operate
under normal circumstances. Excluded are transient
patients' beds, incubators, bassinets, labor beds, and
recovery beds.
Source: MEDCOM 311 RT (Bed Capacity and Bed Status
Report) and the Walter Reed AMC auditing department.
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"• Outpatient Visits - Reported for each outpatient who
presents himself/herself at an MTF for medical advice,
diagnosis, treatment, or complete physical examination, or
who is treated or observed in his home or quarters by
medical personnel. Numbers are for the period: FY 91, FY
92, and the first six months of FY 93.
Source: Headquarters Outpatient System (HOPS).
"* Pharmaceutical Funds - Money obligated during FY 91, FY
92, and the first six months of FY 93 for consumable
supplies, i.e., pharmaceuticals.
Source: Naval Standard Claimant Accounting System and the
Walter Reed Army Medical Center (AMC) pharmacy.
"• Pharmacy Units - The weighted number of pharmacy units for
inpatients and outpatients. The number for outpatient
pharmacy units includes all prescriptions and other issues
which are provided to ambulatory patients, or are issued
to clinics, services, etc. which support ambulatory
patients. The number for inpatient pharmacy units
includes all pharmacy processes which provide drug
products to support inpatient prescriptions, unit dose
distribution, intravenous admixture, or other systems.
Numbers are for the period: FY 91, FY 92, and the first
six months of FY 93.
Source: Worldwide Outpatient Reporting System (WORS).
The y-value, or dependent variable, of the regression equation
is defined as:
* Recoupment - Average dollar amount per month of refunds,
merchandise credit, or replacement products that the MTF
has received, or can expect to receive, from
manufacturers.
Source: For actual amounts received, individual Military
Treatment Facilities.
After determining the utility of the sample regression
equations, and the utility of the individual predictor
variables, there was a need to predict the amount of
recoupment the hospitals/clinics could expect. To determine
the predicted values of recoupment for the hospitals/clinics,
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their predictor-variable values were substituted into the
sample regression equation:
g = b o + blx lp + . . + b kx kp
The resultant predicted values were then summed up to achieve
final estimates. Those estimates were averaged to produce the
dollar amount per month that the Navy could expect to recoup
if they return their expired pharmaceuticals.
The hospital/clinics used for this study were BUMED MTFs
located in the continental United States. A summary of those
facilities is in Table I. The method of data collection was
via individual pharmacy records, civilian return company
records, and Navy Health Care databases. Returned goods
recoupment data was obtained on four Navy MTFs. Those MTFs
were selected by the Navy Surgeon General's Specialty Advisor
for Pharmacy. They are a representative sample of the entire
continental United States Navy health care system, and each
facility had been returning their expired pharmaceuticals.
One non-Navy MTF utilized during the study was Walter Reed
Army Medical Center (AMC), see Table I. Due to its similarity
with Navy facilities, it was chosen as an additional data
source, since Navy data was scarce. Because of the
limitations already noted in Chapter I, no civilian facilities
were used.
27
Table I: PROFILE OF CONUS MTFs




Portsmouth, VA Hospital 446
San Diego 393




Bremerton 98+ Bed 109




Millington 50-98 Bed 66
Newport Hospital 59
Beaufort Below 50 Beds 49















"* Walter Reed AMC Major 570
Teaching
"* U.S. Army Hospital
Facility
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B. COST ZFFZCTIVZNZSS OF CONTRACTING CIVILIAN SZRVICIS
To determine whether it is cost effective to contract
civilian services for the return and disposal of expired Navy
pharmaceuticals, an analysis of the following alternatives was
done.
1. Navy MTFs do not return expired pharmaceuticals.
2. Individual Navy MTFs return their own expired
pharmaceuticals.
3. The Navy establishes centralized locations within the
Navy to process expired pharmaceuticals.
4. The Navy contracts civilian services for the return and
disposal of expired pharmaceuticals.
A detailed analysis using actual costs was not possible.
Since most Naval commands do not allocate all costs to final
outputs, accurate and meaningful cost data was not available.
Alternatively, advantages and disadvantages of each choice
were discussed, and compared with the others.
This chapter outlined the methods and structure of the
analysis that was used when conducting this study. The next
chapter will present the data, and provide the analysis.
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IV. DATA AND ANALYSIS
A. DOLLAR AMOUNIT OF NAVY RETUVRNS
The use of multiple linear regression techniques to
analyze the Navy MTFs' recoupment behavior provided a basis
for analysis. This section will introduce the data and steps
used in determining the sample regression equations. The
sample regression equations will then be used to make
predictions about the Navy's population of CONUS
hospitals/clinics.
1. Sample Data Set
The sample data set, used when determining the sample
regression equations, is displayed in Table II. The entire
population data set is in Appendix C.
Table 1I: SAMPLE DATA SET
FACILITY RECOUP- CATCH- BED ADMIS- OCC BED AVERAGE
MENT MENT # SIONS DAYS LOS
POP
BETHESDA $12,072 84,158 342 42,577 238,564 5.61















G R O T O N $ 3,75 0 4 5 , 3 2 1 2 5 5 , 4 8 1 1 2 , 9 5 1 2 . 3 6
WALTER $74,986 274,077 789 66,293 577,365 8.71
R ETO N AC 
4 5 , 3 2 1 2 5 
5 , 4 8 1 1 2 
, 9 5 1 2 .3 6
KINGS BAY $4,379 N/A N/A N/A N/A N/A
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Table II (Continued): SAMPLE DATA SIT
FACILITY ADPL PHARM UNITS OUT PT PHARM FUNDS
VISITS
BETHESDA 261.58 4,420,637 1,450,099 $39,801,684
CAMP 95.44 2,089,074 1,289,171 $13,665,875
PENDLE-
TON
GROTON 14.20 763,189 572,920 $7,277,443
WALTER 632.38 4,586,291 1,694,392 $44,550,000
REED AMC
KINGr BAY NiA 34,41 J4, 045 $2,616,490
The Walter Reed numbers for admissions and occupied
bed days are thirty-month estimates, based on twelve month
data from FY 92. Similarly, the Walter Reed number for
outpatient visits is a thirty-month estimate, based on twenty-
four month data from FY 91 and FY 92. This was done due to
the inability to get complete data, and so those particular
numbers would be comparable with the remaining data. Because
of demonstrated consistency from year-to-year, this was
considered reasonable.
The Walter Reed, Camp Pendleton, and Kings Bay
recoupment amounts are the result of expired goods from both
pharmacy items, and items acquired from sources outside the
pharmacy (ships, other MTFs, and supply inventory control
points). The Bethesda and Groton recoupment amounts are the
result of expired goods from only pharmacy items.
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To be of benefit, regression analysis must meet
certain criteria. First, a reasonable degree of causality
must exist that meets economic and professional judgement.
Independent predictor variables used should have some
reasonable relationship with the dependent variable,
Recoupment, the average dollars recouped per month.
Scattergraphs and simple linear regressions for each predictor
variable are contained in Appendix D. These results show that
there is a positive correlation between the independent
predictor variables and Recoupment. Analyzing the sample data
set with simple linear regression, it can be said that
Catchment Area Population is the best predictor of Recoupment,
and the equation is:
RECOUPMENT = - 15354 + 0.324 CATCHMENT
As discussed below, using a single predictor variable may not
always be appropriate, and multiple variables should be
analyzed.
a. Catchment Area Population Eatimates
It can be expected that the larger the catchment
area population, the greater the amount of patients that will
receive service provided by the MTF, and the greater the
possibility for recoupment. However, catchment area
populations may not be homogeneous because demographics are
different throughout the country. One area may include a
large percent of retirees needing more pharmaceutical
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services, whereas another area may have a younger active duty
population requiring fewer services. In addition, Naval
Medical .Clinics Commands do not have designated catchment area
populations.
b. Number of Beds
Presumably, the more beds a hospital has, the more
care it provides, and the greater the recoupment. There still
may be variables, such as whether or not the beds are filled,
what patient types are occupying those beds, and there is the
fact that clinics do not have beds.
c. Admissions
Generally, the more patients that are admitted into
a MTF, the more services that are required, and the greater
the recoupment. However, the types of patients admitted will
affect the amount of pharmacy services required.
d. Occupied Bed Days
The greater the amount of beds that are filled and
the longer the beds are filled, the more services can be
expected, and the greater the recoupment. Again, it depends
on the types of patients occupying those beds, and their
requirements.
e. ALOS and ADPL
Both of these are based on other predictor
variables (admissions, occupied bed days), and should be
highly correlated with those variables.
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f. PhazuaacyUnits
As the amount of weighted pharmacy units increases,
the amount of recoupment should increase. Weighted
procedures, which are used for the pharmacy, reflect the
relative complexity and costliness of the services, not the
pharmaceuticals. It is possible to have a complex procedure
for an inexpensive item.
g. Outpatient Visits
With more outpatient visits, pharmacy services
could be expected to increase, and recoupment should follow.
But, the outpatients might require inexpensive
pharmaceuticals, or possibly none at all.
h. Pharmacy Funds
One would expect that the more a pharmacy spends on
pharmaceuticals, the greater the recoupment. Each pharmacy is
issued an operating budget. The management of that budget,
and the management of the pharmacy inventory, are factors that
can influence the amount of recoupment.
2. Multiple Linear Regreaslon Analysis
Multiple linear regressions were performed for the
following situations:
"* Using only the sample hospitals (Walter Reed, Bethesda,
Camp Pendleton, and Groton)
"* Using.the hospitals, and the sample clinic (Walter Reed,
Bethesda, Camp Pendleton, Groton and Kings Bay)
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The best of the results, for all the possible combinations,
are reported in Appendix E. A constant observation was that
the Walter Reed data had a large influence in obtaining the
regression equations.
While attempting to use the best multiple regression
equation to predict the amount of expected recoupment, by
inserting the population data into the equation, two obstacles
were encountered.
1. Some individual hospital predictions came up negative,
and others did not seem reasonable, see Table III.
2. Because the regression equation was derived from the
situation that examined only the sample data from the
hospitals, the regression equation involved Occupied Bed
Days. Therefore, since clinics do not have Occupied Bed
Days, it could not be used directly to make predictions
for the clinics.
Although the results in Table III may not have been
what was expected for each individual hospital, the "Total
Value of Recoupment Estimate (V),11 was expected. In a study
of returned goods done on wholesale distribution centers, the
data showed returned goods constitute approximately 3.75% of
the average wholesaler's gross sales (Benfield, 1993). Since
MTF pharmacies are end users, their percentage should be less
than 3.75%, possibly one or two percent. The Total Value of
Recoupment Estimate in Table III equates to one percent of the
total monthly amount of the hospital pharmacy funds expended;
which is in the expected range.
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Table IV: RECOUPMINT ESTIMATES USING REGRESSION EQUATION
Regression RECOUPMENT = 9646 + 0.200 OCC BED DAYS
Equation - 0.00113 PHARMACY FUNDS
HOSPITAL OCC DID PHARMACY RUCOUPMNTZ
DAYS FUNDS USTIXATI
BEAUFORT 26,410 $5,244,011 $9,002
BETHESDA 238,564 $39,801,684 $12,383
BREMERTON 55,030 $10,219,829 $9,104
CAMP LEJEUNE 87,283 $13,979,389 $11,306
CAMP PEN5LETON 87,038 S13,665,875 $11,611
"CHARLESTCN 87,451 016,071,320 $8,976
CHERRY POINT 14,816 $4,646,899 $7,358
CORPUS CHRISTI 26,980 $7,004,585 $7,127
GREAT LAKES 67,318 $11,700,403 $9,888
GROTON 12,951 $7,277,443 $4,013
JACKSONVILLE 66,504 $2S,404,966 -$5,761
LEMOORE 7,808 S3,611,752 $7,126
LON]G BEACH 69,233 011,-482,808 $10,529
MILLINOTON 27,661 08,802,869 $5,231
NEWPORT 32,589 $6,845,467 $8,428
-'AK HARBOR 12,339 03,851,387 $7,762
OAKLAND 135,968 $28,235,566 $4,933
ORLANDO 58,545 $18,492,954 $458
PATUXENT RIVER 5,935 $2,863,899 $7,597
PENSACOLA 57,108 $19,913,887 -$1,435
PORTSMOUTH, VA 269,627 $67,653,899 -$12,878
SAN DIEGO 318,204 $62,913,269 $2,195
TWENTYNINE 11,620 $2,380,477 $9,280PALMS ______ _______
TOTAL VALUE OF RECOUPMENT ESTIMATE (V) $134,233
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Because of the noted difficulties, it was decided to
use a set of regression equations for predicting:
Regressions = {Regression,, Regression 2, ... Regressions)
Also, additional regressions were obtained, after removing the
influential Walter Reed data. The best of those results are
reported in Appendix F.
From all of the regressions that were done, the best
five were selected based on their statistical significance.
Those regression equations, and their corresponding Total
Values of Recoupment Estimates, are summarized in Table IV.
Table V: REGRESSION EQUATIONS AND RECOUPMENT VALUES
Rege-sion Equations Data Source Used Total Value
For Regression of Recoupmont
Estimate (V)
RECOUPMENT = 9646 + Walter Reed, $134,233
0.200 OCC BED DAYS - Bethesda, Camp
0.00113 PHARMACY FUNDS Pendleton, Groton
RECOUPMENT = 9874 + 154 Walter Reed, $192,412
BEDS - 0.00127 PHARMACY Bethesda, Camp
FUNDS Pendleton, Groton
RECOUPMENT = 2906 - Bethesda, Camp $175,556
0.000940 PHARMACY FUNDS Pendleton, Groton,
+ 0.0105 PHARMACY UNITS Kings Bay
RECOUPMENT = -15354 + Walter Reed, $243,962
0.324 CATCHMENT AREA Bethesda, Camp
POPULATION Pendleton, Groton
RECOUPMENT = 11120 + Walter Reed, $161,3840.184 OCC BED DAYS 
- Bethesda, Camp
0.00927 PHARMACY UNITS Pendleton, Groton
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The resulting Total Values of Recoupment Estimates
continued to be reasonable, so their mean was used to predict
the estimated total monthly recoupment for the hospitals. The
set of Total Values of Recoupment Estimates is displayed in
Figure 3, along with a reference value, which is 1.5% of total





V= = ($134;33 + $161,3M + $175556 + $192,412 + $243X ) 15 $181,0
Figure 3: Total Values of Recoupment Estimates
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The mean of the Total Values of Recoupment Estimates
was $181,509. Dividing the mean by the aggregate average
monthly amount of hospital pharmacy funds expended yielded:
$181,509 / $13,068,821 = 1.38887%
-That percentage of monthly recoupment for hospitals
was then applied to the aggregate monthly amount of pharmacy
funds expended at the clinics to get the total clinics'
estimate.
$907,607 * 1.38887% = $12,605
Finally, summing the mean total for the hospitals with
the total clinics' estimate gave the complete estimate of
expected recoupment per month.
$181,509 + $12,605 = $194,114 EXPECTED RECOUPMENT PER MONTH
Multiplying by twelve months gave the final annual estimate.
$194,114 PER MONTH * 12 MONTHS = $2,329,368 PER YEAR
The dollar amount that the Navy can expect to recoup through
the return of their expired pharmaceuticals at CONUS MTFs is
$2,329,368 PER YEAR.
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B. COST NFYNCTXIVBMSS OF CONT1'RACTING CIVILIAN SZRVICZS
To reach a conclusion as to the best, or most cost
effective, method that should be used by the Navy when
managing expired pharmaceuticals, four situations were
analyzed and compared.
1. Navy NTFs Do Not Return Rxpired Pharmaceuticals
For most Navy MTFs this is the status quo.
Accumulation of expired pharmaceuticals must be handled by the
MTF personnel.
a. Disadvantagea
(1) Disposal. As already mentioned in Chapter II,
disposal of pharmaceutical waste has become increasingly more
difficult. If the Navy processes their expired
pharmaceuticals with internal assets, then each location where
this is done would be considered a waste generator, and have
to be licensed by the Environmental Protection Agency. All
destructible items would have to be lab packed and manifested.
The waste would have to be categorized and segregated by
hazardous and non-hazardous. To comply with Food and Drug
Administration regulations, tracking of the waste must be
done. Also, regulations require a special provision of safety
at facilities that handle hazardous waste, along with training
programs, special twenty-four hour responders, etc. (Lehmann,
1993)
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Outdated pharmaceuticals are listed as "special
waste," not to be confused with red bag waste. Special waste
must be incinerated at an approved site. The closure of
hospital incinerators, and new regulations, have forced MTFs
to contract for disposal.
While contracted disposal is often more expensive than on-
site treatment, it reduces the hospital's risk of sinking
a large capital expense into a technology that may become
obsolete by rapidly developing regulations and technology.
Contracted disposal can also offer flexibility when waste
quantities fluctuate greatly....
Contracted disposal does place some increased risk on a
facility in terms of accountability or responsibility for
the waste. It is the responsibility of the generating
facility to ensure that the ... waste contractor is
running a legitimate operation which is in compliance of
all applicable laws .... Legitimate ... waste contractors
often offer tours of their facilities and upon completion
of these tours they issue certificates to their clients.
Through this process, a hospital can document that a
reasonable effort was made to check the legitimacy of the
contractor. While this may not relieve the hospital of
ultimate responsibility for the waste, it does show the
intent of the hospital to comply with applicable
regulations. (Hamilton, 1992)
No matter who handles the disposal of
pharmaceutical waste, there are risks for the Navy. ¶fEreare
social risks that are associated with the mismanagement of the
disposal of pharmaceutical waste. These are mainly the poor
public relations that are caused when mismanagement occurs, or
even if there is a perception that there is mismanagement of
pharmaceutical waste. When poor public relations are used to
fuel negative feelings toward the Navy, this social risk then
becomes a political risk for the Navy. (Hamilton, 1992)
Legal risks include the violation of Federal, State, or
local environmental regulations, occupational health and
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safety regulations, and legal disputes associated with
waste disposal contracts. .... the wide range of locations
and platforms from which the Navy conducts healthcare
increases the legal risks associated with ... waste
management. (Hamilton, 1992)
Through reductions in the volume of
pharmaceutical waste, the Navy can minimize the risks and
costs associated with the management of that waste.
Pharmaceutical waste minimization can be achieved through
source reduction and/or manufacturer returns.
(2) Loss of revenue. By not participating in an
expired pharmaceutical return program, MTFs are foregoing the
opportunity to receive manufacturer refunds. As seen earlier
in this chapter, the loss of revenue can be significant. In
these austere times, this is an opportunity cost that the Navy
cannot continue to forfeit.
b. Advantage
(1) Increased incentive to minimize. The Navy
should always have the incentive to minimize the amount of
expired pharmaceuticals. Whether it is a disposal cost, or a
cost to return, there will always be a cost attached to
expired. pharmaceuticals. This choice may give an added
incentive to the Navy to decrease their expired
pharmaceuticals, particularly considering the revenues
foregone.
Currently, BUMED is in the process of switching
all their MTFs to "Prime Vendor." This is scheduled to be
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completed in FY 94. Prime Vendor has shown the ability to
reduce the number of pharmaceutical products stored in MTFs.
A reduction of inventory will directly decrease the amount of
expired pharmaceuticals.
Newly developed inventory management systems,
such as bar coding, can provide timely and accurate inventory
data, help reduce replenishment errors, and help with tracking
expiration dates and usage rates. As new technology evolves,
and is incorporated, overordering errors and lack of stock
rotation will diminish. As a result, pharmaceutical
expirations previously caused by inventory management problems
should decrease.
"In FY 88, the military services entered into
an agreement with the Food and Drug Administration (FDA) to
have expired pharmaceuticals potency tested and, if the
results showed 93 percent or higher of original potency, the
pharmaceuticals would be extended up to two additional years
(Walters, .1993)." This Shelf-Life Extension Program, outlined
in BUMEDINST 6710.62A, has the potential to decrease the
amount of expired pharmaceuticals. However, its usefulness
for hospitals/clinics is limited by implementation guidelines.
The value of items to be tested must be $5,000 or more per
National Stock Number (NSN); this may be difficult to meet.
Additionally, the detailed requests for extension are not
always acted on with enough lead time so replacement products
can be requisitioned in time.
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A drawback is that all programs that have
potentialto reduce the amount of expired pharmaceuticals cost
money. The cost of each Shelf-Life Extension Program test is
between $27,000 and $52,000. New technology inventory systems
require a capital expenditure and training. The prime vendor
charges a fee for their inventory management and distribution
services.
2. Navy MTFs Return Their Own Expired Pharmaceuticals
-This situation calls for each MTF to perform the
entire return process with internal assets.
a. Disadvantages
(1) Legality. The Small Business Administration
and Investment Act states:
The essence of the American economic system of private
enterprise is free competition. Only through full and
free competition can free markets, free entry into
business, and opportunities for the expression and growth
of personal initiative and judgement be assured. The
preservation and expansion of such competition is basic
not only to the economic well-being but to the security of
this Nation. Such security and well-being cannot be
realized unless the actual and potential capacity of small
business is encouraged and developed. It is the declared
policy of the Congress that the Government should aid,
counsel, assist, and protect insofar as is possible the
interests of small-business concerns in order to preserve
free competitive enterprise, to insure that a fair
proportion of the total purchases and contracts for
supplies and services for the Government be placed with
small-business enterprises, and to maintain and strengthen
the overall economy of the Nation. (Public Law 163,
Chapter 282, Title II, Sec. 202)
The Navy is not in the business of returning
expired pharmaceuticals, and is charged by Congress to protect
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the interests of small-business concerns. It follows that the
Navy would be perceived as wrong in pursuing an internal
pharmaceutical returns program.
(2) Time and labor. As already spelled out in
Chapter II, the pursuit of pharmaceutical returns is highly
time and labor intensive. Tracking of manufacturer policies
and tracking the returns themselves can be a full-time job.
There are also the sorting, administrative paperwork, and
disposal functions. Experience has shown that at small MTFs
a satisfactory job can be done using two people five days each
quarter. Large MTFs would require more worker-days.
Currently, some small facilities have the
personnel available to perform the returns; but, even now,
large facilities do not have sufficient personnel. In the
future, with declining budgets, personnel manning can be
expected to decrease, and the opportunity for returns to be
done internally may be lost at all facilities.
(3) Credits and refunds. An issue that has arisen
since military facilities have been returning expired
pharmaceuticals is how to handle the manufacturer credits and
refunds. As introduced in Chapter II, credits accumulate due
to the DoD accounting procedures, and refunds must be
deposited in a U.S. Treasury account, vice the MTF's account.
With the arrival of Prime Vendor, the credits
problem can be alleviated by notifying all product
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manufacturers tj send all credit memos for the return of all
creditable items to the prime vendor. The prime vendor can
then act as a clearing house for the processing of all credit
return memos from the various product manufacturers.
The refund issue can be dealt with by
introducing and gaining approval for an exception to Title 31,
Section 3302 of the United States Code. An exception can be
written similarly to the law that pertains to collections from
third-party payers, where the MTF collects from a third-party
payer (insurance, medical service, or health plan) the
reasonable costs of health care services incurred by the
United States on behalf of a covered beneficiary. It states,
"Amounts collected under this section from a third-party payer
for the costs of health care services provided at a facility
of the uniformed services shall be credited to the
appropriation supporting the maintenance and operation of the
facility."(10 U.S.C. 1095) Allowing the MTFs to retain the
refunds would give them added incentive to pursue returning
expired pharmaceuticals, even when they expect refunds.
(4) Disposal. The problems with pharmaceutical
disposal have been discussed in the previous choice, and
remain the same. Even if the Navy MTFs return some expired




(1) The Navy receives compensation. Instead of
foregoing the opportunity provided by the manufacturers, in
this case the Navy endeavors to recover the potential revenues
of their expired pharmaceuticals. However, there is the risk
that the MTFs will not secure all possible revenues. Failure
to acquire and comply with all manufacturer policies, along
with not being timely, may result in reduced returns.
(2) Increased incentive to minimize. This has
aiready been discussed, and remains the same.
3. The Navy Establishes Centralized Locations Within The
Navy To Process Expired Pharmaceuticals
This alternative examines the situation where the Navy
starts up their own centralized program to return their
expired pharmaceuticals. A program could be operated out of
one location; or, two locations, one on the east coast and one
on the west coast.
a. Disadvantages
(1) Start up costs. Either a new facility must be
built, or an existing facility must be modified. Forklifts,
tables, computers, and other property will be required. The
facility must be manned, by personnel transferred or hired,
and these personnel must be trained.
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There will be a period of less than optimal
performance as learning and data acquisition occurs. Some
potential revenue will be lost during this period.
(2) Future needs. With the arrival of Prime
Vendor, it is possible that the future amounts of expired Navy
pharmaceuticals will not support a Navy-run facility.
Therefore, it may not be cost effective to activate a facility
that may be demanded for only two or three years.
(3) Legality. As discussed before, it may not be
judged favorably, in the light of the Small Business Act, if
the Navy creates a return business of their own.
(4) Disposal. The disposal problem has been
discussed previously.
b. Advantages
(1) Economies of scale. By having centralized
operations, the Navy can minimize the resources necessary to
return their expired pharmaceuticals. Duplication of effort
will be eliminated. Importantly, only one data base must be
maintained, saving numerous work-hours. Also, there will be
a single point of contact for the manufacturers, resulting in
faster response and better service.
(2) Relieves MTFs. In this situation, the MTFs
will just have to collect and ship their expired items. Their
personnel can put more effort toward their regular duties.
48
(3) The Navy receives compensation. As with the
previous choice, the Navy will attempt to recover the
potential revenues of their expired pharmaceuticals. In this
instance, the amount recovered should be greater due to
increased efficiencies. Dedicated personnel, a more detailed
and accurate data base, and better manufacturer relations will
aid in the improvement.
(4) Allows monitoring. This alternative will allow
centralized monitoring, and reporting, of the amount and
status of each MTF's expired pharmaceuticals. It can be
expected that the MTFs will strive to minimize their amounts,
possibly encouraged by their superiors. This may become a
disadvantage, if MTFs, fearing repercussions, fail to ship
expired goods, resulting in lost revenue.
4. The Navy Contracts Civilian Services For The Return
And Disposal Of Expired Pharmaceuticals
The Navy institutes a policy that all MTFs will return
their expired pharmaceuticals through the use of civilian
services. A contract could be written so one civilian return
service handles all Navy returns, or each MTF could contract
individually with their choice of civilian return service.
a. Disadvantagea
(1) Costs of service/disposal. Civilian companies
charge a fee for their service of returning expired
pharmaceuticals. Depending on the contract, the fee charged
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might be by weight of the goods processed, by a set percentage
of the dollar amount returned, or by another method. Anyhow,
the Navy does not receive the entire amount that they could
realize if they had done the returns themselves.
Similarly, the civilian services charge a fee
to dispose of pharmaceutical waste. Although most places in
the Navy already pay for disposal of hazardous and non-
hazardous waste, the fees charged by the civilian return
services could be slightly higher.
There is also the risk that the Navy will pay
more in disposal fees than the revenues that can be generated
from their expired pharmaceuticals. To many of hazardous,
non-returnable drugs, and not enough of revenue producing
returnable drugs, could cause this situation. Figure 4
attempts to illustrate this effect.
00 / Types of Drug
Figure 4: Revenue/Cost vs Types of Drugs
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(2) Contracting and monitoring. Before awarding a
contract in the Navy, bids must be solicited and evaluated.
Post-award involves contract administration and monitoring.
These activities, which can take considerable time and effort,
are unique to this alternative.
b. Advantages
(1) Easy. Except for contracting/monitoring, this
alternative is easy on the MTFs. All that is required by the
MTFs is to box and ship/deliver all expired pharmaceuticals to
the civilian return service. The civilian return service
handles all aspects of the returns, and sends inventory,
tracking, and destruction reports to the MTFs.
(2) Maximum returns. Using civilian return
services, the Navy can expect maximum returns. The civilian
services have been in business for a length of time, and,
through their learning curve, and access to necessary
information, should be able to optimize the amount of returns.
(3) Disposal. Allowing the civilian services to
dispose of the outdated pharmaceutical waste will lessen the
work for the Navy, and help ensure responsible destruction.
Also, special waste handling procedures and training will not
have to be implemented.
The Navy needs a new strategy to handle expired
pharmaceuticals. They can continue with their current status,
but there is an opportunity to increase revenues through the
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return of all expired goods, and this opportunity should not
be missed.
Of the two choices where the Navy uses internal
assets to process returns, clearly using centralized locations
is superior. Less resources are involved, and more revenues
can be expected.
That leads to the decision between using
centralized Navy facilities, or contracting civilian services,
to do the returns. The Navy should not venture into an
enterprise that may not be legal, nor cost effective.
Although there are costs involved with contracting civilian
services for the returns and disposal, those costs will be
more than covered by the revenues generated by the returns.
Thereforei the Navy's strategy should embrace the alternative
of contracting civilian services for the return and disposal
of their expired pharmaceuticals. How to implement that
selection is beyond the scope of this thesis.
This chapter presented the data and analysis.
The next chapter will provide a summary of this study, and
recommendations.
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V. SUIAIRY AND RECOIAIZNDATIONS
A. SU~iQIRY
This study was conducted to determine: (1) the dollar
amount of savings that the Navy could expect if they return
their expired pharmaceutical products, and (2) whether it is
cost effective to contract civilian services for the return
and disposal of these expired products.
The first chapter introduced the problem. It emphasized
that, as military budgets continue to decline, military health
care personnel must exploit new management methods in an
effort to maximize efficiency and cost containment. A
proposed potential source of additional revenue was the return
of outdated pharmaceutical products to drug manufacturers for
refund, credit, or replacement products.
The review of literature presented background information
pertaining to the return and disposal of expired
pharmaceuticals. It showed that the dramatic rise in
pharmaceutical prices, and the returned goods opportunity
provided by the manufacturers, give a focus for cost
containment efforts. A discussion of where the Navy's expired
pharmaceuticals originate, and the various methods of managing
expired pharmaceuticals, was done. Additionally, three
important concerns were introduced: pharmaceutical disposal,
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changing manufacturers' policies, and the handling of
manufacturer credits and refunds.
Inferential methods in linear regression were used to
quantify the dollar amount of savings that the Navy could
expect if they return their expired pharmaceuticals. The
scope of the study was limited to the Navy's CONUS MTF's.
Difficulties were encountered due to scarcity of data.
Analysis found that sample data from one hospital had
significant influence when obtaining the regression equations.
Results from the regressions lead to some individual hospital
estimates that were negative, and some that were not
reasonable. Additionally, estimates for the Navy clinics
could not be made directly using the regression equations.
Ultimately, an average of the aggregate values of recoupment
for the hospitals, given by the five top linear regression
equations, was used to predict over two million dollars per
year as the total expected recoupment at CONUS MTFs.
Finally, the advantages and disadvantages of four possible
methods to manage the Navy's expired pharmaceuticals were
discussed. A comparison of the four yielded the conclusion
that the best, or most cost effective, method is to contract




Based on the findings of this study, the following
recommendations have been made:
"* The Navy should initiate a universal program for the
return of it's expired pharmaceuticals.
"* The Navy should contract civilian services for the return
and disposal of their expired pharmaceuticals.
"* Contracts should be written to ensure manufacturer credits
are sent to the MTFs' prime vendor.
"* The Navy should propose legislation that will allow the
MTFs to retain their manufacturer refunds.
While doing this study, it became apparent that the Navy
can truly benefit through the return of it's expired
pharmaceuticals. The Navy must be proactive, and initiate a
universal policy directing the return and disposal of expired
pharmaceutical products utilizing civilian services. This
action will aid in controlling Navy health care costs in the
future.
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"APPENDIX A - EXAMPLES OF MANUFACTURERS' POLICIES
RETURNS
Lederle will, in its sole discretion and judgment, consider all justifiable requests tot
exchange or credit. Loderle wilt, providing the conditions stated below are met, Issue credits
to direct accounts and only exchange merchandise with nondirect accounts. Such return
requests will be subject to home office approval and to the conditions noted below.
Conditions
Requests for credit must be made on Ledefle's Return Goods Memorandum foim which
may be obtained from the Distribution Center servicing the customer of the local sales
representative.
Returns will be evaluated at the actual purchase price of the quantity being returned.
All merchandise to be returned, unless otherwlse directed, must be shipped prepaid to
the Central Return Center located at the following address: j.WS "Abarýd
oC Y Alin: Cemtral Rotumrs Osp., I 10 East Business center Dr..
Loderle representatives are not authorized to remove or transport merchandise that is to
be returned from any place of business.
Credit for outdated opened packages of less than original unit of sale, will be prorated
down to the nearest halt package.
Ledarle reserves the right to destroy without credit, exchange or return to the customer,
any returned merchandise which in Its judgment is not returnable under the limitations set
forth below.
Nonretumable
Merchandise expressly sold on a nonreturnable basis or which has been involved in a fire
sale, sacrifice sale or bankruptcy sale or has been, in the judgment of Lederle, subjected to
improper storage conditions.
Products damaged by fire, smoke, heat or water resulting from a fire or other casualty
occurrence or insurable hazard.
Products that have been deleted from the price list for a period of one year or more or
dated products which ae outdated more than one year beyond the expiration date on the
package.
Merchandise with broken seals or OR less than the original unit of sale,
M= u %hlhch is salable but the return ot which is intended to reduce inventory
temporarily.
Merchandise obtained from a V.A.. Military or U.S.PIH. Depot.
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APPMDZX A (Continuesd)
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furthser processing. Standard Auttegg.E featun.et Goods coedul
provisions wsially o rfo etdemwjshtppong ator omerchendess comwovd
"wee than 30 days afterthe1 Dim"i wshmarl
3. "eurns due to ordering wmmt wnse be shipmed freigt prepowd.
C Avatheqked Returns
AU tms omwpetd for am& MM be In esidile for resteabimig. in full.
ummeLemed. momnvod orlfelg A~n Nplpesg casos. EEWFT products
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ALPPENDIX 3 - EXAMPLES OF FOJRMS FOR RE7tUNS
PLEASE PRINT CLEARLY WITH BALL POINT PEN
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APPENDIX B (Continued)
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APPENDIX 2 (Cont inued)
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APPENDIX B (Continued)
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AFPPNDIX D - SCA•TR •RAPHS AND SIPLE LINZIAR REGRESSIONS
Recoupment vs Catchment Pop
CATOHMENT AREA POULATIONd
Using all hospitals (Walter Reed, Bethesda, Camp Pendleton,
Groton), the regression equation is:
RECOUPMENT = - 15354 + 0.324 CATCHMENT
Predictor Coef Stdev t-ratio p
Constant -15354 4760 -3.23 0.084
CATCHMENT 0.32411 0.03090 10.49 0.009
s = 5416 R-sq = 98.2% R-sq(adj) = 97.3%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 3226018560 3226018560 109.99 0.009






Using all hospitals, the regression equation is:
RECOUPMENT = - 3710 + 92.2 BEDS
Predictor Coef Stdev t-ratio p
Constant -3710 9486 -0.39 0.733
BEDS 92.19 21.84 4.22 0.052
s = 12875 R-sq = 89.9% R-sq(adi) = 84.9%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 2953162496 2953162496 17.82 0.052









Using all hospitals, the regression equation is:
RECOUPMENT = - 10686 + 1.08 ADMISSIONS
Predictor Coef Stdev t-ratio p
Constant -10686 17825 -0.60 0.610
ADMISSIONS 1.0812 0.4373 2.47 0.132
s = 20120 R-sq = 75.4% R-sq(adj) = 63.0%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 2475034112 2475034112 6.11 0.132




Recoupment vs Occ Bed Days
Using all hospitals, the regression equation is:
RECOUPMENT - 3159 + 0.126 OCCUPIED BED DAYS
Predictor Coef Stdev t-ratio p
Constant -3159 8819 -0.36 0.754
OCCBDAYS 0.12603 0.02796 4.51 0.046
s = 12131 R-sq = 91.0% R-sq(adj) = 86.6%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 2990367744 2990367744 20.32 0.046






AVEPAGE LENG•h OF IAY
Using all hospitals, the regression equation is:
RECOUPMENT = - 33711 + 11332 ALOS
Predictor Coef Stdev t-ratio p
Constant -33711 20359 -1.66 0.240
ALOS 11332 3553 3.19 0.086
s = 16428 R--sq = 83.6% R-sq(adj) =75.4%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 2744939264 2744939264 10.17 0.086
Error 2 539741760 269870880Total 3 3284680960
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APPIIDIX D (Continued)
Recoupment vs ADPL
AVEPAGE DALY PAIIENT LOAD
Using all hospitals, the regression equation is:
RECOUPMENT = - 3168 + 115 ADPL
Predictor Coef Stdev t-ratio p
Constant -3168 8834 -0.36 0.754
ADPL 115.05 25.56 4.50 0.046
s = 12148 R-sq = 91.0% R-sq(adj) = 86.5%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 2989519616 2989519616 20.26 0.046




Recoupment vs Pharm Units
0 1==00,0•0,0&0 300 400= &0MO
Using all hospitals and Kings Bay clinic, the regression equation
is:
RECOUPMENT = - 3965 + 0.0104 PHARMACY UNITS
Predictor Coef Stdev t-ratio p
Constant -3965 19235 -0.21 0.850
UNITS 0.010409 0.006367 1.63 0.201
s = 25360 R-sq = 47.1% R-sq(adj) = 29.5%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 1718946688 1718946688 2.67 0.201
Error 3 1929359744 643119936
Total 4 3648306432
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APPD'ZX D (Cont inued)
Recoupment vs Out Pt Visits
I io
Using all hospitals and Kings Bay clinic, the regression equation
is:
RECOUPMENT = - 13113 + 0.0330 OUTPATIENT VISITS
Predictor Coef Stdev t-ratio p
Constant -13113 24359 -0.54 0.628
OUTVSTS 0.03304 0.02057 1.61 0.207
s = 25569 R-sq = 46.2% R-sq(adj) = 28.3%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 1686913408 1686913408 2.58 0.207
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Using all hospitals and Kings Bay clinic, the regression equation
is:
RECOUPMENT = - 3408 + 0.00115 PHARMACY FUNDS
Predictor Coef Stdev t-ratio p
Constant -3408 16956 -0.20 0.854
FUNDS 0.0011510 0.0006138 1.88 0.157
s = 23662 R-sq = 54.0% R-sq(adj) 38.6%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 1968672128 1968672128 3.52 0.157
Error 3 1679634304 559878080
Total 4 3648306432
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"APPENDIX 2 - MULTIPLE LINEAR MEGRESSIONS
Using just hospitals (Walter Reed, Bethesda, Camp Pendleton, and
Groton), the regression equation is:
RECOUPMENT = 9646 - 0.00113 PHARMACY FUNDS + 0.200 OCC BED DAYS
Predictor Coef Stdev t-ratio p
Constant 9645.5 454.0 21.25 0.030
FUNDS -0.00112913 0.00002891 -39.06 0.016
OCCBDAYS 0.200352 0.002145 93.39 0.007
s = 433.5 R-sq = 100.0% R-sq(adj) = 100.0%
Analysis of Variance
SOURCE DF SS MS F p
Regression 2 3284493056 1642246528 8740.38 0.008
Error 1 187892 187892
Total 3 3284680960




Obs. FUNDS RECOUP Fit Stdev.Fit Residual St.Resid
1 44550000 74986 75019 432 -33 -1.00 X
2 39801684 12072 12100 433 -28 -1.00 X
X denotes an obs. whose X value gives it large influence.
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APPENDIX I (Continued)
Using just hospitals (Walter Reed, Bethesda, Camp Pendleton,
and Groton), the regression equation is:
RECOUPMENT = 9874 - 0.00127 PHARMACY FUNDS + 154 BEDS
Predictor Coef Stdev t-ratio p
Constant 9874 1264 7.81 0.081
FUNDS -0.00126704 0.00008400 
-15.08 0.042
BEDS 154.163 4.589 33.60 0.019
s = 1204 R-sq = 100.0% R-sq(adj) = 99.9%
Analysis of Variance
SOURCE DF SS MS F p
Regression 2 3283230208 1641615104 1131.59 0.021
Error 1 1450717 1450717
Total 3 3284680960




Obs. FUNDS RECOUP Fit Stdev.Fit Residual St.Resid
1 44550000 74986 75062 1202 
-76 -1.00 X
2 39801684 12072 12167 1201 
-95 -1.00 X
X denotes an obs. whose X value gives it large influence.
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APPZNDZX 2 (Continuod)
Using just hospitals (Walter Reed, Bethesda, Camp Pendleton,
and Groton), the regression equation is:
RECOUPMENT = 11120 - 0.00927 PHARMACY UNITS + 0.184 OCC BED DAYS
Predictor Coef Stdev t-ratio p
Constant 11120 6007 1.85 0.315
UNITS -0.009270 0.003020 -3.07 0.201
OCCBDAYS 0.18410 0.02241 8.22 0.077
s = 5247 R-sq = 99.2% R-sq(adj) = 97.5%
Analysis of Variance
SOURCE DF SS MS F p
Regression 2 3257152768 1628576384 59.16 0.092
Error 1 27528220 27528220
Total 3 3284680960




Obs. UNITS RECOUP Fit Stdev.Fit Residual St.Resid
1 4586291 74986 74897 5246 89 1.00 X
X denotes an obs. whose X value gives it large influence.
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APPZNDIX 3 (Continued)
Using all hospitals and the one clinic (Walter Reed, Bethesda,
Camp Pendleton, Groton, and Kings Bay), the regression equation
is:
RECOUPMENT = - 16901 + 0.00833 PHARMACY FUNDS + 0.0832 OUTPATIENT
VISITS - 0.0937 PHARMACY UNITS
Predictor Coef Stdev t-ratio p
Constant -16901 27077 -0.62 0.645
FUNDS 0.008334 0.005780 1.44 0.386
OUTVSTS 0.08320 0.07343 1.13 0.460
UNITS -0.09366 0.07136 -1.31 0.414
s = 24754 R-sq = 83.2% R-sq(adj) = 32.8%
Analysis of Variance
SOURCE DF SS MS F p
Regression 3 3035525376 1011841792 1.65 0.507
Error 1 612781056 612781056
Total 4 3648306432






Using all the hospitals and the one clinic (Walter Reed, Bethesda,
Camp Pendleton, Groton, and Kings Bay), the regression equation
is:
RECOUPMENT = 3337 + 0.00410 PHARMACY FUNDS - 0.0289 PHARMACY UNITS
Predictor Coef Stdev t-ratio p
Constant 3337 21749 0.15 0.892
FUNDS 0.004101 0.004713 0.87 0.476
UNITS -0.02885 0.04561 -0.63 0.592
s = 26453 R-sq = 61.6% R-sq(adj) = 23.3%
Analysis of Variance
SOURCE DF SS MS F p
Regression 2 2248735232 1124367616 1.61 0.384
Error 2 1399571200 699785600
Total 4 3648306432




"APPENDIX F - REGRESSIONS WITHOUT WALTER REED DATA
Using only three hospitals (Bethesda, Camp Pendleton, and Groton),
the regression equation is:
RECOUPMENT = - 1880 + 0.0101 OUTPATIENT VISITS
Predictor Coef Stdev t-ratio p
Constant -1880 1956 -0.96 0.512
OUTVSTS 0.010099 0.001674 6.03 0.105
s = 1106 R-sq = 97.3% R-sq(adj) = 94.7%
Analysis of Variance
SOURCE DF SS MS F p
Regression 1 44481224 44481224 36.39 0.105
Error 1 1222467 1222467
Total 2 45703692
Using three hospitals and the one clinic (Bethesda, Camp
Pendleton, Groton, and Kings Bay), the regression equation is:
RECOUPMENT = 2906 + 0.0105 PHARMACY UNITS -0.000940 PHARMACY FUNDS
Predictor Coef Stdev t-ratio p
Constant 2906.1 406.9 7.14 0.089
UNITS 0.0105244 0.0009998 10.53 0.060
FUNDS -0.0009401 0.0001105 -8.50 0.075
s = 494.9 R-sq = 99.6% R-sq(adj) = 98.8%
Analysis of Variance
SOURCE DF SS MS F p
Regression 2 63397740 31698870 129.43 0.062
Error 1 244917 244917
Total 3 63642656
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